Dabrafenib for treating unresectable, advanced or metastatic BRAFV600 mutation-positive melanoma (ID605)
Fleeman N, Bagust A, Beale S, Boland A, Dickson R, Dwan K, et al.
Record ID 32014000503
English
Details
Project Status:
Completed
URL for project:
https://www.journalslibrary.nihr.ac.uk/programmes/hta/125401/#/
Year Published:
2014
URL for published report:
https://www.journalslibrary.nihr.ac.uk/programmes/hta/125401/#/
Requestor:
NIHR Health Technology Assessment programme
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England, United Kingdom
MeSH Terms
- Antineoplastic Combined Chemotherapy Protocols
- Melanoma
- Imidazoles
- Antineoplastic Agents
- Protein Kinase Inhibitors
- Oximes
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.